“Chronicity in Revolution” Conference: Innovation, Patients and Value for a Sustainable System
Our director, Ane Fullaondo, took part in the panel discussion on the implementation of innovation, sharing her views on the challenges facing healthcare.
On 7 May, Biosistemak took part in the conference “Chronicity in Revolution: Innovation, Patients and Value for a Sustainable System”, held at the BAT Tower (Bilbao) and organised by the Basque Health Cluster in collaboration with Boehringer Ingelheim. The event brought together representatives from the healthcare system, industry, start-ups and patient associations to reflect on the current challenges of chronicity and the role of innovation in the sustainability of the system.
The Institute’s Scientific Director, Ane Fullaondo, spoke as a panellist at Panel 2: “Implementing innovation: value and sustainability of the system”, where she shared Biosistemak’s perspective on the needs of the healthcare system, with a focus on achieving a real impact on the care of people with chronic conditions.
During the debate, key issues were addressed, such as measuring the real impact of innovation, cost as a misleading indicator compared to long-term sustainability, the role of Innovative Public Procurement, and the importance of strategic public-private partnerships. In her speech, Ane Fullaondo emphasised the need to link research, clinical practice and decision-making, to ensure that innovation delivers real value to the system and to patients.
A forum for dialogue between the healthcare system, industry and patients
The conference began with an institutional opening, followed by the various panel discussions. The programme featured contributions from Gontzal Tamayo, Deputy Minister of Health of the Basque Government, as well as Iñaki Betolaza, from the Basque Government’s Department of Pharmaceutical Access and Innovation, and Nora Ibargoyen, from Osteba-BIOEF, who provided the institutional perspective and insights into the evaluation of the value of health innovations.
The programme included a first panel discussion focusing on the challenges of innovation in chronic care and its implementation, as well as a second panel—in which Biosistemak took part—dedicated to value analysis and the sustainability of the system.
The meeting concluded with a third panel dedicated to the voice of the chronic patient, which highlighted the need to actively involve patients in innovation, evaluation and prioritisation processes. Among others, Aitziber Marcoida spoke at this session, representing the Basque Country branch of the Spanish Diabetes Federation (FEDE), focusing on the patient experience and their role in assessing the value of and access to innovations.
Biosistemak’s participation in this conference reinforces its commitment to applied research, impactful innovation and the continuous improvement of care for people with chronic conditions, contributing to the development of a more sustainable and value-driven healthcare system.
